Up-regulation of cathepsin B and cathepsin L activities in scrapie-infected mouse Neuro2a cells

Journal of General Virology

Volumn 84, Issue 8, 2003, Pages 2279-2283

  Zhang, Yonghua ^a,b   Spiess, Eberhard ^b   Groschup, Martin H ^c   Bürkle, Alexander ^a,b,d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^d UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN L; CELL SURFACE PROTEIN; CYSTEINE PROTEINASE; ISOPROTEIN; PRION PROTEIN; PROTEINASE K;

ANIMAL CELL; CATALYSIS; CELL MEMBRANE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME REGULATION; HYPOTHESIS; LYSOSOME; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROCESSING; SCRAPIE AGENT; SHORT SURVEY; UPREGULATION;

ANIMALS; CATHEPSIN B; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; MICE; NEUROBLASTOMA; NEURONS; PRPSC PROTEINS; SCRAPIE; TUMOR CELLS, CULTURED; UP-REGULATION;

ANIMALIA; SCRAPIE PRION;

EID: 0043169474     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19153-0     Document Type: Short Survey

References (34)

1. Aguzzi, A., Montrasio, F. & Kaeser, P. S. (2001). Prions: health scare and biological challenge. Nat Rev Mol Cell Biol 2, 118-126.
2. Almeida, P. C., Nantes, I. L., Chagas, J. R., Rizzi, C. C., Faljoni-Alario, A., Carmona, E., Juliano, L., Nader, H. B. & Tersariol, I. L. (2001). Cathepsin B activity regulation. Heparin-like glycosaminoglycans protect human cathepsin B from alkaline pH-induced inactivation. J Biol Chem 276, 944-951.
3. Barrett, A. J. & Kirschke, H. (1981). Cathepsin B, cathepsin H and cathepsin L. In Methods in Enzymology, pp. 535-561. Edited by S. P. Colowick & N. O. Kaplan. New York: Academic Press.
4. Bosque, P. J. & Prusiner, S. B. (2000). Cultured cell sublines highly susceptible to prion infection. J Virol 74, 4377-4386.
5. Caughey, B. (1994). Scrapie-associated PrP accumulation and agent replication: effects of sulphated glycosaminoglycan analogues. Philos Trans R Soc Lond Ser B 343, 399-404.
6. Caughey, B. & Chesebro, B. (2001). Transmissible spongiform encephalopathies and prion protein interconversions. Adv Virus Res 56, 277-311.
7. Caughey, B. & Raymond, G. J. (1993). Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 67, 643-650.
8. Caughey, B., Raymond, G. J., Ernst, D. & Race, R. E. (1991). N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 65, 6597-6603.
9. Collinge, J. (2001). Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24, 519-550.
10. Dandoy-Dron, F., Guillo, F., Benboudjema, L., Deslys, J. P., Lasmezas, C., Dormont, D., Tovey, M. G. & Dron, M. (1998). Gene expression in scrapie: cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts. J Biol Chem 273, 7691-7697.
11. Diedrich, J. F., Minnigan, H., Carp, R. I., Whitaker, J. N., Race, R., Frey, W. & Haase, A. T. (1991). Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 65, 4759-4768.
12. Doh-ura, K., Iwaki, T. & Caughey, B. (2000). Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol 74, 4894-4897.
13. Dolbeare, F. A. & Smith, R. E. (1977). Flow cytometric measurement of peptidases with use of 5-nitrosalicylaldehyde and 4-methoxy-beta-naphthylamine derivatives. Clin Chem 23, 1485-1491.
14. Fairbairn, D. W., Carnahan, K. G., Thwaits, R. N., Grigsby, R. V., Holyoak, G. R. & O'Neill, K. L. (1994). Detection of apoptosis induced DNA cleavage in scrapie-infected sheep brain. FEMS Microbiol Lett 115, 341-346.
15. Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O. & Tagliavini, F. (1993). Neurotoxicity of a prion protein fragment. Nature 362, 543-546.
16. Giese, A., Groschup, M. H., Hess, B. & Kretzschmar, H. A. (1995). Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain Pathol 5, 213-221.
17. Gray, F., Chretien, F., Adle-Biassette, H., Dorandeu, A., Ereau, T., Delisle, M. B., Kopp, N., Ironside, J. W. & Vital, C. (1999). Neuronal apoptosis in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 58, 321-328.
18. Guicciardi, M. E., Deussing, J., Miyoshi, H., Bronk, S. F., Svingen, P. A., Peters, C., Kaufmann, S. H. & Gores, G. J. (2000). Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 106, 1127-1137.
19. Ishidoh, K. & Kominami, E. (1995). Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro. Biochem Biophys Res Commun 217, 624-631.
20. Ishisaka, R., Utsumi, T., Kanno, T., Arita, K., Katunuma, N., Akiyama, J. & Utsumi, K. (1999). Participation of a cathepsin L-type protease in the activation of caspase-3. Cell Struct Funct 24, 465-470.
21. Kegel, K. B., Kim, M., Sapp, E., McIntyre, C., Castano, J. G., Aronin, N. & DiFiglia, M. (2000). Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J Neurosci 20, 7268-7278.
22. Kingham, P. J. & Pocock, J. M. (2001). Microglial secreted cathepsin B induces neuronal apoptosis. J Neurochem 76, 1475-1484.
23. Kopacek, J., Sakaguchi, S., Shigematsu, K., Nishida, N., Atarashi, R., Nakaoke, R., Moriuchi, R., Niwa, M. & Katamine, S. (2000). Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease. J Virol 74, 411-417.
24. Lotem, J. & Sachs, L. (1996). Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. Proc Natl Acad Sci U S A 93, 12507-12512.
25. McKinley, M. P., Taraboulos, A., Kenaga, L., Serban, D., Stieber, A., DeArmond, S. J., Prusiner, S. B. & Gonatas, N. (1991). Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest 65, 622-630.
26. Prusiner, S. B. (2001). Shattuck lecture - neurodegenerative diseases and prions. N Engl J Med 344, 1548-1551.
27. Rozman, J., Stojan, J., Kuhelj, R., Turk, V. & Turk, B. (1999). Autocatalytic processing of recombinant human procathepsin B is a bimolecular process. FEBS Lett 459, 358-362.
28. Saborio, G. P., Permanne, B. & Soto, C. (2001). Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-813.
29. Snow, A. D., Wight, T. N., Nochlin, D., Koike, Y., Kimata, K., DeArmond, S. J. & Prusiner, S. B. (1990). Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Sträussler syndrome, Creutzfeldt-Jakob disease and scrapie. Lab Invest 63, 601-611.
30. Ulbricht, B., Spiess, E., Schwartz-Albiez, R. & Ebert, W. (1995). Quantification of intracellular cathepsin activities in human lung tumor cell lines by flow cytometry. Biol Chem Hoppe Seyler 376, 407-414.
31. Vancompernolle, K., Van Herreweghe, F, Pynaert, G. & 7 other authors (1998). Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett 438, 150-158.
32. Sc-dependent cell-free formation of protease-resistant prion protein. EMBO J 20, 377-386.
33. Yamashima, T. (2000). Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 62, 273-295.
34. Zhang, Y., Poirier, G. G. & Bürkle, A. (2002). In situ analysis of cellular poly(ADP-ribose) production in scrapie-infected mouse neuroblastoma cells. Histochem J 34, 357-363.